echoloc
Get started
echoloc/ Companies/ Alamar Biosciences, Inc.

Alamar Biosciences, Inc. Tech Stack

High-sensitivity multiplex protein analysis platform with automated workflow

Biotechnology Research Fremont, California 51–200 employees Founded 2018 Privately Held
alamarbio.com LinkedIn

Alamar Biosciences manufactures precision proteomics hardware and assay chemistry for ultra-sensitive protein detection. The stack reveals a hybrid biotech operations profile: qPCR and ddPCR dominate the lab layer, while Benchling and Opentrons support assay development and automation; commercial infrastructure (Salesforce, HubSpot, NetSuite, Power BI) is mature relative to company size. Hiring velocity is accelerating across research, sales, and engineering, while pain-point patterns expose the core bottleneck—scaling manufacturing and process transfer from R&D to production while expanding the assay portfolio and entering regulated markets (China, Japan).

Tech Stack 29 technologies

Core StackSolidWorks Salesforce HubSpot Power BI Python NetSuite Lucidchart Miro Greenhouse Flask C# QuickBooks SAP Delta Lake Unity Catalog qPCR GraphPad Prism Argo CD ddPCR Shiny JMP Benchling Visio Streamlit Tecan Opentrons

What Alamar Biosciences, Inc. Is Building

◆Challenges

  • Expanding commercial organization
  • Regulatory compliance in china
  • Transferring new processes to manufacturing
  • Meeting commercial targets
  • Expanding assay and consumables portfolio
  • Launching new products
  • Improving biomarker detection sensitivity
  • Process transfer from r&d to manufacturing
  • Scalable cost-effective lyophilization production
  • Accurate financial reporting

▲Active Projects

  • Continuous improvement of lyophilization processes
  • Automation platform integration
  • Product validation for new product/processes introduction
  • Ivd immunoassay development on nulisa
  • Qc scale-up implementation
  • New product introductions (npi)
  • Content strategy for consumables portfolio
  • Kol network development
  • New biomarker detection experiments
  • Japan commercial strategy

Hiring Activity

Accelerating25 roles · 20 in 30d

Department

Research
4
Sales
4
Engineering
3
Finance
3
Product
3
Manufacturing
2
Ops
2
HR
1

Seniority

Senior
7
Manager
5
Mid
5
Junior
2
Director
1
Intern
1
Lead
1
Principal
1
Company intelligence

Find more companies like Alamar Biosciences, Inc. by tech stack, pain points and active projects

Get started free

About Alamar Biosciences, Inc.

Alamar Biosciences develops automated proteomics platforms for high-throughput, multiplexed protein analysis. The core product is NULISA™ Chemistry, a sequential capture-and-release method that reduces background noise and expands dynamic range, paired with the ARGO System for fully automated sample-to-data workflows in under 30 minutes of hands-on time. The NULISAseq Inflammation Panel targets immune and inflammatory disease markers, supporting both qPCR and NGS readouts. The company is privately held, based in Fremont, California, and operates across three geographies (US, China, Japan), with active projects spanning lyophilization optimization, process transfer to manufacturing, assay expansion, and KOL network development in emerging markets.

HeadquartersFremont, California
Company Size51–200 employees
Founded2018
Hiring MarketsUnited States, China, Japan

Frequently Asked Questions

What is Alamar Biosciences' core technology?

NULISA™ Chemistry, a proprietary sequential capture-and-release method that reduces background signal and increases sensitivity and dynamic range in multiplex protein analysis. The ARGO System automates the full workflow from sample to data in under 30 minutes.

What does Alamar Biosciences' NULISAseq panel measure?

The NULISAseq Inflammation Panel contains 200+ biomarkers related to immune and inflammatory diseases. It supports both qPCR and NGS readouts on the ARGO System.

Similar Companies in Biotechnology Research

Other companies in the same industry, closest in size

R
Redbock - an NES Fircroft company
Biotechnology Research
C
Capricor Therapeutics, Inc.
Biotechnology Research
K
Kriya Therapeutics, Inc.
Biotechnology Research
B
BigHat Biosciences
Biotechnology Research

How this profile is built

Alamar Biosciences, Inc.'s technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →

This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.